We report a case of a 9-week-old presenting in diabetic ketoacidosis and later diagnosed with an activating ABCC8 mutation who is in the process of transitioning from insulin therapy to sulfonylurea. This evidence concerns the gene ABCC8 and diabetic ketoacidosis.